Pharma Market Access Insights - from Petauri Evidence

Navigating US payer evidence needs to optimise market access


Listen Later

Send us a text

What clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How should evidence be generated, synthesised, and presented for the US market?

In this episode, Clare Foy (Director – Global Market Access, Mtech Access) interviews colleagues Nicole Lodowski (Managing Director, Petauri Evidence) and Bob Nordyke (Senior Advisor, Petauri Evidence) about US payer evidence challenges.

We explore the evolving evidence needs for US payers. Nicole and Bob share unique perspectives around their extensive experience of driving evidence strategies for US pharmaceutical and medical device launches. Additionally, Nicole and Bob share a ‘sneak peek’ of exclusive insights from a recent Petauri US payer insights survey conducted to better understand the evidence landscape from the US payers’ perspective.

They explore:

  • The evolving payer evidence landscape in the US
  • Preferences for clinical and economic evidence by US payers
  • Key differences between the US and other global markets with regard to evidence, HEOR, and market access
  • Opportunities and challenges when launching new medicines/medical devices/diagnostics in the US
  • Innovative perspectives on evidence planning and strategy for the US market
  • US payers’ perspectives, with exclusive insights from Petauri Evidence’s 2024 US payer survey


This episode was first broadcast as a live webinar in October 2024. Learn more at: https://mtechaccess.co.uk/navigating-us-payer-evidence-needs/

Explore more about launching in the US market: https://mtechaccess.co.uk/launching-healthcare-products-in-the-us/

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

...more
View all episodesView all episodes
Download on the App Store

Pharma Market Access Insights - from Petauri EvidenceBy Petauri Evidence

  • 3
  • 3
  • 3
  • 3
  • 3

3

2 ratings


More shows like Pharma Market Access Insights - from Petauri Evidence

View all
Economist Podcasts by The Economist

Economist Podcasts

4,197 Listeners

Medicine and Science from The BMJ by The BMJ

Medicine and Science from The BMJ

41 Listeners

Freakonomics Radio by Freakonomics Radio + Stitcher

Freakonomics Radio

32,106 Listeners

Hidden Brain by Hidden Brain, Shankar Vedantam

Hidden Brain

43,327 Listeners

Up First from NPR by NPR

Up First from NPR

55,934 Listeners

KFF Health News' 'What the Health?' by KFF Health News

KFF Health News' 'What the Health?'

479 Listeners

The Readout Loud by STAT

The Readout Loud

316 Listeners

FT News Briefing by Financial Times

FT News Briefing

676 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

5,945 Listeners

Tradeoffs by Tradeoffs

Tradeoffs

390 Listeners

Finshots Daily by Finshots

Finshots Daily

44 Listeners

MAP - Market Access Podcast by Dr. Stefan Walzer

MAP - Market Access Podcast

0 Listeners

Market Access Matters by Access Infinity

Market Access Matters

0 Listeners

Pharma and BioTech Daily by Pharma and BioTech News

Pharma and BioTech Daily

12 Listeners

RealPharma: Conversations with Pharma Pathfinders by RealPharma

RealPharma: Conversations with Pharma Pathfinders

12 Listeners